Page last updated: 2024-10-31

metyrapone and Infections, Coronavirus

metyrapone has been researched along with Infections, Coronavirus in 2 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Newell-Price, J1
Nieman, LK1
Reincke, M1
Tabarin, A1
Beretta, F1
Dassie, F1
Parolin, M1
Boscari, F1
Barbot, M1
Busetto, L1
Mioni, R1
De Carlo, E1
Scaroni, C1
Fallo, F1
Vettor, R1
Maffei, P1

Other Studies

2 other studies available for metyrapone and Infections, Coronavirus

ArticleYear
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of Cushing's syndrome.
    European journal of endocrinology, 2020, Volume: 183, Issue:1

    Topics: 14-alpha Demethylase Inhibitors; ACTH-Secreting Pituitary Adenoma; Adenoma; Coronavirus Infections;

2020
Practical Considerations for the Management of Cushing's Disease and COVID-19: A Case Report.
    Frontiers in endocrinology, 2020, Volume: 11

    Topics: Aged; Anti-Inflammatory Agents; Antimetabolites; Betacoronavirus; Coronavirus Infections; COVID-19;

2020